Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-04

Clinical Trial Update: Safety and Efficacy of Fecal Microbiota Transplantation in a Population With Bipolar Disorder [Phase 2, Phase 3]

View source ↗

Summary

A Clinical Trials update reports safety and efficacy data for fecal microbiota transplantation in bipolar depression, spanning Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Valerie Taylor | Conditions: Bipolar Depression | Phase 2, Phase 3 | Status: UNKNOWN